24 results on '"Jordan, Emmet"'
Search Results
2. Second‐line chemotherapy in advanced biliary cancers: A retrospective, multicenter analysis of outcomes
3. Acanthosis Nigricans in a Patient with Urothelial Carcinoma Treated with PD-L1 Inhibitor Avelumab, and Secondary Adrenal Insufficiency
4. YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics
5. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
6. Adenoid cystic carcinoma of the prostate – A rare case of genitourinary malignancy
7. Abstract PS12-25: Patterns of treatment and outcomes in real world patients with advanced estrogen receptor positive breast cancer receiving palbociclib and endocrine therapy
8. AKT1 E17K Inhibits Cancer Cell Migration by Abrogating β-Catenin Signaling
9. Atypical Stevens–Johnson syndrome caused by pembrolizumab in the treatment of metastatic melanoma – Are corticosteroids a safe treatment option?
10. ERCC2 Helicase Domain Mutations Confer Nucleotide Excision Repair Deficiency and Drive Cisplatin Sensitivity in Muscle-Invasive Bladder Cancer
11. 105Ageism in Studies of Inpatient Delirium
12. Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention
13. Concurrent Alterations in EGFR-Mutant Lung Cancers Associated with Resistance to EGFR Kinase Inhibitors and Characterization of MTOR as a Mediator of Resistance
14. Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms
15. Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical Phenotype
16. Case report: primary acinar cell carcinoma of the liver treated with multimodality therapy
17. Erratum: Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
18. DNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial Carcinoma
19. YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics.
20. Clinical and Molecular Analysis of Adenosquamous Carcinoma of the Pancreas.
21. Social supports in patients with cancer attending an Irish cancer center: a cross-sectional study.
22. miRNAs as biomarkers of therapeutic response to HER2-targeted treatment in breast cancer: A systematic review.
23. AKT1 E17K Inhibits Cancer Cell Migration by Abrogating β-Catenin Signaling.
24. Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.